MayTech Global Investments’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-55
Closed -$39K 59
2020
Q3
$39K Sell
55
-3,190
-98% -$2.49M 0.01% 41
2020
Q2
$2.57M Buy
3,245
+16
+0.5% +$12.1K 0.81% 24
2020
Q1
$1.92M Sell
3,229
-115
-3% -$112K 0.88% 25
2019
Q4
$3.8M Buy
3,344
+889
+36% +$966K 1.65% 20
2019
Q3
$2.92M Buy
2,455
+59
+2% +$90.1K 1.44% 22
2019
Q2
$3.95M Buy
2,396
+66
+3% +$114K 1.98% 20
2019
Q1
$4.75M Buy
2,330
+1,903
+446% +$3.35M 2.51% 18
2018
Q4
$549K Sell
427
-1,601
-79% -$2.46M 0.35% 24
2018
Q3
$3.83M Buy
2,028
+291
+17% +$601K 1.86% 21
2018
Q2
$3.53M Buy
1,737
+385
+28% +$878K 1.97% 21
2018
Q1
$2.99M Buy
1,352
+80
+6% +$203K 1.75% 22
2017
Q4
$2.94M Buy
+1,272
New +$2.58M 1.93% 21

Other funds holding BLUE

MayTech Global Investments's BLUE Position: Q4 2020 in Review

MayTech Global Investments sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 55 shares — an estimated $39K sold.

MayTech Global Investments first reported a position in BLUE in Q4 2017 and held it in 12 quarters. The position peaked at $4.75M in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • MayTech Global Investments reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • MayTech Global Investments sold 55 bluebird bio shares in Q4 2020, an estimated $39K.
  • MayTech Global Investments first reported a position in bluebird bio in Q4 2017 and held it in 12 quarters.
  • MayTech Global Investments's bluebird bio position peaked at $4.75M in Q1 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on MayTech Global Investments's 13F filing for Q4 2020, filed 10 Feb 2021.